Sh2023 Hill Colin

Colin Hill

Co-Founder and CEO, Aitia

Colin Hill is CEO of Aitia Bio, which he co-founded in 2000. In 2020 the company launched the world’s first Virtual Patients, beginning in multiple myeloma and followed by prostate cancer and Alzheimer’s disease. Hill serves on the board of Centrexion Therapeutics, previously served on the boards of Biotelemetry and PPD, and was a founding member of the boards of AesRx and of TMed (Transforming Medicine: The Elizabeth Kauffman Institute). In 2016, he was appointed to the Massachusetts Digital Health Council. Hill was founding chairman of O’Reilly Media’s Strata Rx in 2012. In 2004, Hill was named to MIT Technology Review’s Innovators Under 35. He has appeared in The Wall Street Journal, Nature, The Boston Globe, Politico, Forbes, Wired, The Economist, and other publications and media outlets.

Thank you for signing up!

Please provide a valid email address.

Please provide a valid email address.
aerial 2019 campus
Sign up to receive the latest news from Aspen Ideas.